Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6095007 | Gastroenterology | 2013 | 37 Pages |
Abstract
IDO1, which catabolizes tryptophan, promotes colitis-associated tumorigenesis in mice, independent of its ability to limit T-cell-mediated immune surveillance. The epithelial cell-autonomous survival advantage provided by IDO1 to colon epithelial cells indicate its potential as a therapeutic target.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Ameet I. Thaker, M. Suprada Rao, Kumar S. Bishnupuri, Thomas A. Kerr, Lynne Foster, Jeffrey M. Marinshaw, Rodney D. Newberry, William F. Stenson, Matthew A. Ciorba,